Qualifi, a leading brand in reproductive health and genetic screening, specializes in non-invasive prenatal testing for Down syndrome via maternal blood sampling, delivering results within just seven days. Operating under Next Generation Genomic Co., Ltd. (NGG Thailand), it adheres to high standards recognized in the USA and focuses on advanced laboratory services across ASEAN.

Qualifi's expertise encompasses various facets of in-vitro fertilization (IVF) and fertility treatments. Their offerings include Preimplantation Genetic Screening (PGS), Preimplantation Genetic Diagnosis (PGD), sperm preparation, and hormone testing. Utilizing cutting-edge technology like Next-Generation Sequencing (NGS) and Array Comparative Genomic Hybridization (aCGH), Qualifi ensures accurate chromosome analysis for embryos, enhancing success rates in pregnancy while minimizing miscarriage risks.

With over a decade of experience, Qualifi provides medical professionals with reliable results and essential tools to support patient care without the burden of expensive lab setups. Their commitment to advancing reproductive genetics makes them a trusted partner in the field.